Coronavirus update for Friday, May 15 as of 2:30 p.m.
NASH wrote on Thursday to Health and Human Services Secretary Azar and CMS Administrator Seema Verma to point out a published report describing the degree to which its second distribution of Provider Relief Fund money, based on hospitals’ net revenue, disadvantaged hospitals that serve especially high proportions of publicly insured patients. See NASH’s letter here.
Centers for Medicare & Medicaid Services
- CMS released a bulletin that gives guidance to states on how to temporarily modify provider payment methodologies and capitation rates under their Medicaid managed care contracts to address the impact of the COVID-19 emergency while preserving systems of care and access to services for Medicaid beneficiaries. See CMS’s announcement of the bulletin here and find the bulletin itself here.
- CMS updated its COVID-19 FAQ on Medicare fee-for-serving billing with new information about accountable care organizations that terminate their Shared Savings Program agreement (p. 40).
- HHS’s Office of the Inspector General updated its FAQ addressing how it will apply its administrative enforcement authorities to arrangements directly connected to the COVID-19 public health emergency. The new information makes clear the circumstances under which a physician group that contracts with a nursing home to provide care to its residents could furnish protective face masks to the nursing home at no or reduced cost during the COVID-19 crisis.
- HHS’s Office of Civil Rights published a notice of enforcement discretion informing interested parties that it will not impose penalties for non-compliance with regulatory requirements under the HIPAA rules against covered health care providers and their business associates in connection with their good-faith participation in the operation of a community-based testing site during the public health emergency.
- In the past week CMS issued 13 section 1135 waivers to give states greater flexibility to serve their Medicaid beneficiaries during the COVID-19 public health emergency. The states receiving waivers this week are Alabama, Alaska, California, Connecticut, Georgia, Indiana, Louisiana, Massachusetts, Minnesota, Missouri, Nebraska, and Oregon and the District of Columbia.
- CMS posted a message announcing temporary changes in its Medicare Diabetes Prevention Program as a result of the COVID-19 crisis.
- CMS issued a call for nominations for individuals to serve on its Coronavirus Commission on Safety and Quality in Nursing Homes. The commission process will be led by a contractor that will, among other things, manage the nomination and selection of commission members.
Department of Health and Human Services
HHS and its Agency for Healthcare Research and Quality (AHRQ) will award $5 million in fiscal year 2020 to support novel, high-impact studies that evaluate the responsiveness of health care delivery systems, health care professionals, and the overall U.S. health care system to the COVID-19 pandemic. See HHS’s announcement of the grant program here and find the full funding announcement here.
Centers for Disease Control and Prevention
The CDC issued a health advisory through its health alert network with background information on several cases of a recently reported multi-system inflammatory syndrome in children (MIS-C) associated with COVID-19. The advisory includes a case definition for this syndrome and the CDC’s recommendation that providers report any patient who meets the case definition to local, state, and territorial health departments to enhance knowledge of risk factors, pathogenesis, clinical course, and treatment of this syndrome.
Food and Drug Administration
- The FDA issued a news release alerting the public to early data that suggests potentially inaccurate results from using the Abbott ID NOW point-of-care test to diagnose COVID-19. Specifically, the test may return false negative results.
- The FDA issued an update to its guidance for pharmacy compounders that experience shortages of the personal protective equipment they typically use to compound human drugs that are intended or expected to be sterile. In the update, FDA clarifies that drugs can be compounded under the policy in a segregated compounding area that is not in a cleanroom when specific beyond-use dates are used.
Federal Funding Opportunities for Hospitals
- NASH has prepared a document that collects and presents in one place the various new federal funding opportunities for hospitals resulting from legislation addressing the COVID-19 public health emergency. Find that document here.
(To receive this daily update directly, sign up for our mailing list at email@example.com.)